SPYGLASS PHARMA, INC.

SpyGlass Pharma, Inc.

Equities

SGP

US85220G1094

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-13 pm EDT			5-day change	1st Jan Change
26.55 ^USD	+0.49%		-0.49%	-

Mar. 10	HC Wainwright Initiates SpyGlass Pharma at Buy With $37 Price Target	MT
Mar. 09	SpyGlass Says Phase 1/2 Trial of BIM-IOL System Shows Patients Achieve Decrease in Intraocular Pressure	MT

Leerink Initiates at Outperform With $42 Price Target

Published on 03/03/2026 at 07:26 am EST

MT Newswires

Lock

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

© MT Newswires - 2026

Latest news about SpyGlass Pharma, Inc.

Mar. 10	HC Wainwright Initiates SpyGlass Pharma at Buy With $37 Price Target	MT
Mar. 09	SpyGlass Says Phase 1/2 Trial of BIM-IOL System Shows Patients Achieve Decrease in Intraocular Pressure	MT
Mar. 09	SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results For Its Innovative BIM-IOL System	CI
Mar. 03	Leerink Initiates SpyGlass Pharma at Outperform With $42 Price Target	MT
Mar. 03	Stifel Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
Mar. 03	Citigroup Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
Mar. 03	Leerink Initiates at Outperform With $42 Price Target	MT
Mar. 03	Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target	MT
Feb. 23	Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO	RE
Feb. 11	Spyglass Pharma Insider Bought Shares Worth $5,000,000, According to a Recent SEC Filing	MT
Feb. 09	SpyGlass Pharma Closes $172.5 Million IPO	MT
Feb. 09	Spyglass Pharma, Inc. Appoints Habib Dable to the Board of Directors, Effective February 5, 2026	CI
Feb. 09	SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to NASDAQ Composite Index	CI
Feb. 06	SpyGlass Pharma Shares Rise in Nasdaq Debut	MT
Feb. 06	SpyGlass Pharma Prices $150 Million IPO	MT

Chart SpyGlass Pharma, Inc.

Duration

Period

Chart SpyGlass Pharma, Inc.

SGP: Dynamic Chart

Company Profile

Employees

32

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

26.55USD

Average target price

45.00USD

Spread / Average Target

+69.49%

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Stock Market
Stock Market News
Leerink Initiates at Outperform With $42 Price Target

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW